These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12237286)

  • 1. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.
    Castle PE; Wacholder S; Lorincz AT; Scott DR; Sherman ME; Glass AG; Rush BB; Schussler JE; Schiffman M
    J Natl Cancer Inst; 2002 Sep; 94(18):1406-14. PubMed ID: 12237286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
    Khan MJ; Castle PE; Lorincz AT; Wacholder S; Sherman M; Scott DR; Rush BB; Glass AG; Schiffman M
    J Natl Cancer Inst; 2005 Jul; 97(14):1072-9. PubMed ID: 16030305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology.
    McIntyre-Seltman K; Castle PE; Guido R; Schiffman M; Wheeler CM;
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1165-70. PubMed ID: 15894667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
    Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
    J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology.
    Castle PE; Walker JL; Schiffman M; Wheeler CM
    Int J Cancer; 2005 Dec; 117(6):1007-12. PubMed ID: 15986443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions.
    Liaw KL; Glass AG; Manos MM; Greer CE; Scott DR; Sherman M; Burk RD; Kurman RJ; Wacholder S; Rush BB; Cadell DM; Lawler P; Tabor D; Schiffman M
    J Natl Cancer Inst; 1999 Jun; 91(11):954-60. PubMed ID: 10359548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus and the long-term risk of cervical neoplasia.
    van der Graaf Y; Molijn A; Doornewaard H; Quint W; van Doorn LJ; van den Tweel J
    Am J Epidemiol; 2002 Jul; 156(2):158-64. PubMed ID: 12117707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of smoking on high-grade cervical cancer in women on the basis of human papillomavirus infection studies.
    Fang JH; Yu XM; Zhang SH; Yang Y
    J Cancer Res Ther; 2018; 14(Supplement):S184-S189. PubMed ID: 29578171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking.
    Castellsagué X; Muñoz N
    J Natl Cancer Inst Monogr; 2003; (31):20-8. PubMed ID: 12807941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort.
    Peto J; Gilham C; Deacon J; Taylor C; Evans C; Binns W; Haywood M; Elanko N; Coleman D; Yule R; Desai M
    Br J Cancer; 2004 Aug; 91(5):942-53. PubMed ID: 15292939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions Between High- and Low-Risk HPV Types Reduce the Risk of Squamous Cervical Cancer.
    Sundström K; Ploner A; Arnheim-Dahlström L; Eloranta S; Palmgren J; Adami HO; Ylitalo Helm N; Sparén P; Dillner J
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26160881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies.
    ; Appleby P; Beral V; Berrington de González A; Colin D; Franceschi S; Goodill A; Green J; Peto J; Plummer M; Sweetland S
    Int J Cancer; 2006 Mar; 118(6):1481-95. PubMed ID: 16206285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study.
    Schiffman M; Glass AG; Wentzensen N; Rush BB; Castle PE; Scott DR; Buckland J; Sherman ME; Rydzak G; Kirk P; Lorincz AT; Wacholder S; Burk RD
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1398-409. PubMed ID: 21602310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia.
    Ho GY; Kadish AS; Burk RD; Basu J; Palan PR; Mikhail M; Romney SL
    Int J Cancer; 1998 Oct; 78(3):281-5. PubMed ID: 9766558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort.
    Deacon JM; Evans CD; Yule R; Desai M; Binns W; Taylor C; Peto J
    Br J Cancer; 2000 Dec; 83(11):1565-72. PubMed ID: 11076670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology.
    Khan MJ; Partridge EE; Wang SS; Schiffman M
    Cancer; 2005 Jul; 104(1):61-70. PubMed ID: 15889450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica.
    Hildesheim A; Herrero R; Castle PE; Wacholder S; Bratti MC; Sherman ME; Lorincz AT; Burk RD; Morales J; Rodriguez AC; Helgesen K; Alfaro M; Hutchinson M; Balmaceda I; Greenberg M; Schiffman M
    Br J Cancer; 2001 May; 84(9):1219-26. PubMed ID: 11336474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
    Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
    N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.